scholarly journals Acetylation of serotonin in vitro by a human N-acetyltransferase

1969 ◽  
Vol 113 (4) ◽  
pp. 721-725 ◽  
Author(s):  
Thomas A. White ◽  
John W. Jenne ◽  
David A. Price Evans
Keyword(s):  
Genetic Polymorphism ◽  
Liver Enzyme ◽  
Human Liver ◽  
Natural Substrate ◽  
Enzyme Preparations ◽  
Wide Variability ◽  
Human Livers

1. There is a well-recognized genetic polymorphism for the N-acetylation of isoniazid and sulphamethazine by human livers. 2. Serotonin was found to be acetylated by human liver enzyme preparations and the N-acetylserotonin formed was identified and determined quantitatively. 3. In 13 livers examined there was a wide variability in the capacity to acetylate serotonin that did not correlate with the capacity of the same livers to acetylate isoniazid and sulphamethazine. The results suggest that serotonin is not a natural substrate for the polymorphic N-acetyltransferase and that it may be acetylated by a different enzyme.

Reduction of 7-ketolithocholic acid by human liver enzyme preparations in vitro

1989 ◽  
Vol 256 (1) ◽  
pp. G67-G71
Author(s):  
Y. Amuro ◽  
W. Yamade ◽  
K. Kudo ◽  
T. Yamamoto ◽  
T. Hada ◽  
...  
Keyword(s):  
Gas Chromatography ◽  
Liver Enzyme ◽  
Chenodeoxycholic Acid ◽  
Human Liver ◽  
Potassium Phosphate ◽  
Gas Chromatography Mass Spectrometry ◽  
Potassium Phosphate Buffer ◽  
Sodium Potassium ◽  
Enzyme Preparations

The formation of chenodeoxycholic and ursodeoxycholic acids from 7-ketolithocholic acid by human liver preparations was examined in vitro. Liver preparations were incubated with 7-ketolithocholic acid at pH 5.5 in a sodium-potassium-phosphate buffer containing NADPH or NADH. The products formed were analyzed by gas chromatography and gas chromatography-mass spectrometry. Results showed that chenodeoxycholic and ursodeoxycholic acids could be formed from 7-ketolithocholic acid by human liver enzyme(s). The enzyme(s) required NADPH but not NADH as coenzyme and was localized largely in the microsomes. The conjugated 7-ketolithocholic acid, especially the taurine conjugated, was predominantly reduced to chenodeoxycholic acid, whereas the unconjugated 7-ketolithocholic acid was not reduced well to either chenodeoxycholic acid or ursodeoxycholic acid. Thus the reduction of 7-ketolithocholic acid by human liver enzyme(s) was found to be dependent on whether the substrate was conjugated or not.

scholarly journals Progress in human liver organoids

2020 ◽  
Vol 12 (8) ◽  
pp. 607-617
Author(s):  
Lulu Sun ◽  
Lijian Hui
Keyword(s):  
Mouse Models ◽  
Human Liver ◽  
Major Goal ◽  
Future Directions ◽  
In Vitro System ◽  
Human Liver Cells ◽  
Human Livers ◽  
Liver Organoids ◽  
Complex Organ

Abstract Understanding the development, regeneration, and disorders of the liver is the major goal in liver biology. Current mechanistic knowledge of human livers has been largely derived from mouse models and cell lines, which fall short in recapitulating the features of human liver cells or the structures and functions of human livers. Organoids as an in vitro system hold the promise to generate organ-like tissues in a dish. Recent advances in human liver organoids also facilitate the understanding of the biology and diseases in this complex organ. Here we review the progress in human liver organoids, mainly focusing on the methods to generate liver organoids, their applications, and possible future directions.

Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5

2005 ◽  
Vol 102 (3) ◽  
pp. 550-556 ◽  
Author(s):  
Theresa Mariero Klees ◽  
Pamela Sheffels ◽  
Kenneth E. Thummel ◽  
Evan D. Kharasch
Keyword(s):  
Human Liver ◽  
Interindividual Variability ◽  
Poor Correlation ◽  
Extensive Metabolism ◽  
Metabolite Ratio ◽  
Cytochrome P450 3A5 ◽  
Human Livers

Background There is considerable unexplained interindividual variability in the clearance of alfentanil. Alfentanil undergoes extensive metabolism by cytochrome P4503A4 (CYP3A4). CYP3A5 is structurally similar to CYP3A4 and metabolizes most CYP3A4 substrates but is polymorphically expressed. Livers with the CYP3A5*1 allele contain higher amounts of the native CYP3A5 protein than livers homozygous for the mutant CYP3A5*3 allele. This investigation tested the hypothesis that alfentanil is a substrate for CYP3A5 and that CYP3A5 pharmacogenetic variability influences human liver alfentanil metabolism. Methods Alfentanil metabolism to noralfentanil and N-phenylpropionamide was determined in microsomes from two groups of human livers, characterized for CYP3A4 and CYP3A5 protein content: low CYP3A5 (2.0-5.2% of total CYP3A, n = 10) and high CYP3A5 (46-76% of total CYP3A, n = 10). Mean CYP3A4 content was the same in both groups. The effects of the CYP3A inhibitors troleandomycin and ketoconazole, the latter being more potent toward CYP3A4, on alfentanil metabolism were also determined. Results In the low versus high CYP3A5 livers, respectively, noralfentanil formation was 77 +/- 31 versus 255 +/- 170 pmol . min . mg, N-phenylpropionamide formation was 8.0 +/- 3.1 versus 20.5 +/- 14.0 pmol . min . mg, and the metabolite ratio was 9.5 +/- 0.4 versus 12.7 +/- 1.4 (P < 0.05 for all). There was a poor correlation between alfentanil metabolism and CYP3A4 content but an excellent correlation when CYP3A5 (i.e., total CYP3A content) was considered (r = 0.81, P < 0.0001). Troleandomycin inhibited alfentanil metabolism similarly in the low and high CYP3A5 livers; ketoconazole inhibition was less in the high CYP3A5 livers. Conclusion In microsomes from human livers expressing the CYP3A5*1 allele and containing higher amounts of CYP3A5 protein, compared with those with the CYP3A5*3 allele and little CYP3A5, there was greater alfentanil metabolism, metabolite ratios more closely resembled those for expressed CYP3A5, and inhibitors with differing CYP3A4 and CYP3A5 selectivities had effects resembling those for expressed CYP3A5. Therefore, alfentanil is metabolized by human liver microsomal CYP3A5 in addition to CYP3A4, and pharmacogenetic variability in CYP3A5 expression significantly influences human liver alfentanil metabolism in vitro. Further investigation is warranted to assess whether the CYP3A5 polymorphism is a factor in the interindividual variability of alfentanil metabolism and clearance in vivo.

scholarly journals The Metabolism of Gammekane and Related Compounds

2021 ◽  
Author(s):  
◽  
Alan Geoffrey Clark
Keyword(s):  
Liver Enzyme ◽  
Gel Filtration ◽  
Dicarboxylic Acids ◽  
In Vitro Metabolism ◽  
Enzyme Preparations ◽  
Sheep Liver ◽  
Lysine Residues ◽  
Complete Exclusion

<p>1. A detailed kinetic study has been made of the glutathione S-aryl-transferases from the New Zealand grass grub (Costelytra zealandica) and from sheep liver. The insect enzyme behaves in accordance with a Michaelis-Menten model for two-substrate enzymes. It is inhibited by the sulphonphthaleins, phthaleins, fluoresceins and dicarboxylic acids competing with glutathione, while the sheep-liver enzyme is not susceptible to this type of inhibition. From this, and other data obtained from a study of the variation of kinetics with pH, it is proposed that two basic groups (possibly lysine residues) are involved in binding of glutathione to the insect enzyme, while only one such group appears in the sheep-liver enzyme. Binding of the aromatic substrate to the enzyme in both species may involve a histidine residue. 2. The accumulation of little significant radioactivity in diluant 2gamma-pentachlorocyclohexene (gamma-PCCH) during the in vitro metabolism of [14C]gamma-hexachlorohexane (gamma-HCH) suggests that the PCCH's are not formed as free intermediates during the metabolism of the HCH's. However, certain ambiguities introduced with the experimental techniques used preclude the complete exclusion of this possibility. 3. gamma-HCH, gamma-PCCH and delta-PCCH metabolized in vivo by M.domestica and C.zealandica and in vitro by preparations from both species, all produce as the principal metabolite a glutathione conjugate with chromatographic properties identical with those of authentic S-(2,4-dichlorophenyl)glutathione. There is, however some doubt as to the identity of the S-substituent moiety. 4. The in vitro metabolism of gamma-HCH and delta-PCCH is glutathione-dependent and is inhibited by various phthaleins and sulphonphthaleins. The in vivo metabolism of delta-PCCH in C.zealandica is profoundly affected by this type of compound, but its effects on the rate of metabolism in vivo of delata-HCH in M.domestica and C.zealandica are only marginal. 5. The enzyme concerned in the metabolism of delta-PCCH has been shown to differ from aryltransferase in M.domestica and C.zealandica by gel filtration techniques and by differences in activity in different enzyme preparations. The delta-PCCH-metabolising activity appears to be associated with a DDT dehydrochlorinase activity. In M.domestica, there appears to be, in addition, a second DDT dehydrochlorinase with only a low cross-specificity towards delta-PCCH.</p>

scholarly journals The Metabolism of Gammekane and Related Compounds

2021 ◽  
Author(s):  
◽  
Alan Geoffrey Clark
Keyword(s):  
Liver Enzyme ◽  
Gel Filtration ◽  
Dicarboxylic Acids ◽  
In Vitro Metabolism ◽  
Enzyme Preparations ◽  
Sheep Liver ◽  
Lysine Residues ◽  
Complete Exclusion

<p>1. A detailed kinetic study has been made of the glutathione S-aryl-transferases from the New Zealand grass grub (Costelytra zealandica) and from sheep liver. The insect enzyme behaves in accordance with a Michaelis-Menten model for two-substrate enzymes. It is inhibited by the sulphonphthaleins, phthaleins, fluoresceins and dicarboxylic acids competing with glutathione, while the sheep-liver enzyme is not susceptible to this type of inhibition. From this, and other data obtained from a study of the variation of kinetics with pH, it is proposed that two basic groups (possibly lysine residues) are involved in binding of glutathione to the insect enzyme, while only one such group appears in the sheep-liver enzyme. Binding of the aromatic substrate to the enzyme in both species may involve a histidine residue. 2. The accumulation of little significant radioactivity in diluant 2gamma-pentachlorocyclohexene (gamma-PCCH) during the in vitro metabolism of [14C]gamma-hexachlorohexane (gamma-HCH) suggests that the PCCH's are not formed as free intermediates during the metabolism of the HCH's. However, certain ambiguities introduced with the experimental techniques used preclude the complete exclusion of this possibility. 3. gamma-HCH, gamma-PCCH and delta-PCCH metabolized in vivo by M.domestica and C.zealandica and in vitro by preparations from both species, all produce as the principal metabolite a glutathione conjugate with chromatographic properties identical with those of authentic S-(2,4-dichlorophenyl)glutathione. There is, however some doubt as to the identity of the S-substituent moiety. 4. The in vitro metabolism of gamma-HCH and delta-PCCH is glutathione-dependent and is inhibited by various phthaleins and sulphonphthaleins. The in vivo metabolism of delta-PCCH in C.zealandica is profoundly affected by this type of compound, but its effects on the rate of metabolism in vivo of delata-HCH in M.domestica and C.zealandica are only marginal. 5. The enzyme concerned in the metabolism of delta-PCCH has been shown to differ from aryltransferase in M.domestica and C.zealandica by gel filtration techniques and by differences in activity in different enzyme preparations. The delta-PCCH-metabolising activity appears to be associated with a DDT dehydrochlorinase activity. In M.domestica, there appears to be, in addition, a second DDT dehydrochlorinase with only a low cross-specificity towards delta-PCCH.</p>

scholarly journals Species differences in the conjugation of 4-hydroxy-3-methoxyphenylethanol with glucuronic acid and sulphuric acid

1976 ◽  
Vol 158 (1) ◽  
pp. 33-37 ◽  
Author(s):  
K P Wong
Keyword(s):  
Human Liver ◽  
High Speed ◽  
Species Differences ◽  
Glucuronic Acid ◽  
Mitochondrial Fraction ◽  
Mouse Kidney ◽  
Enzyme Preparations ◽  
Guinea Pig Liver ◽  
High Speed Supernatant

The biosynthesis of the glucuronide and sulphate conjugates of 4-hydroxy-3-methoxyphenylethanol was demonstrated in vitro by using the high-speed supernatant and microsomal fractions of liver respectively. These two conjugates were also produced simultaneously by using the post-mitochondrial fraction of rat, rabbit or guinea-pig liver. In contrast only the glucuronide was synthesized by human liver and only the sulphate by mouse and cat livers. Neither of these conjugates was formed by the kidney or the small or large intestine of the rat. A high sulphate-conjugating activity was observed in mouse kidney; the rate of sulphation of 4-hydroxy-3-methoxyphenylethanol with kidney homogenate and high-speed supernatant preparations was 1.8 times greater than with liver preparations. The sulpho-conjugates of 4-hydroxy-3-methoxyphenylethanol and 4-hydroxy-3-methoxy-phenylglycol were also formed by enzyme preparations of rabbit adrenal and rat brain; the glycol was the better substrate in the latter system. Mouse brain did not possess any sulphotransferase activity. For the conjugation of 4-hydroxy-3-methoxyphenylethanol by rabbit liver, the Km for UDP-glucuronic acid was 0.22 mM and that for Na2SO4 was 3.45 mM. The sulphotransferase has a greater affinity for 4-hydroxy-3-methoxyphenyl-ethanol than has glucuronyltransferase, as indicated by their respective Km values of 0.036 and 1.3 mM. It was concluded that sulphate conjugation of 4-hydroxy-3-methoxyphenylethanol predominates in most species of animals.

Human liver cell cultivation for long-term in vitro toxicity studies in a miniaturized multi-compartment 3D bioreactor system

2011 ◽  
Vol 49 (01) ◽  
Author(s):  
SA Hoffmann ◽  
M Lübberstedt ◽  
U Müller-Vieira ◽  
D Knobeloch ◽  
A Nüssler ◽  
...  
Keyword(s):  
Liver Cell ◽  
Human Liver ◽  
In Vitro Toxicity ◽  
Cell Cultivation ◽  
Toxicity Studies ◽  
Human Liver Cell ◽  
Bioreactor System
Sign in / Sign up

Export Citation Format

Share Document